Avobis Bio Gets FDA Fast Track for AVB-114 Crohn’s Therapy
Only implantable cell therapy for Crohn’s perianal fistulas with FDA IND clearance and Fast Track designation Avobis Bio LLC, a clinical stage company developing implantable...
Category : Clinical Research, Pharma & Healthcare Financing
IPA & RIBOPRO Partner to Advance mRNA Antibody Discovery
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a global leader in AI-powered antibody discovery and development, today announced a strategic collaboration with RIBOPRO,...
Thermo Fisher Launches CorEvitas SLE Registry & Biorepository
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the CorEvitas Systemic Lupus Erythematosus (SLE) Registry. The multi-center, prospective...
Argobio and Institut Pasteur Launch Enodia for Protein Degradation
Argobio and the Institut Pasteur proudly announce the launch of Enodia Therapeutics, a groundbreaking French biotech company dedicated to block and degrade disease-causing proteins for...
Emalex Biosciences’ Lead Candidate Hits Endpoints in TS Study
Topline data from Phase 3 study in patients with Tourette syndrome shows statistical significance between ecopipam and placebo for both the primary efficacy endpoint in...
MAIA Biotechnology Announces $1.43M Private Placement
MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive...
Zing Health & Karoo Health Partner to Enhance Cardiac Care
To further support momentum in special needs Medicare Advantage plans, Zing will also tap into a portion of Karoo’s national network of 700-plus cardiology provider partners...
Berlin Heals Raises 7M CHF for First Studies on Heart Treatment
Berlin Heals Holding AG, a late stage MedTech start up, has developed a breakthrough method and a product for the therapy of heart failure. The...
CareDx Study: AlloSeq cfDNA Accurately Detects Organ Rejection
AlloSeq cfDNA Consistent with Performance of Proven AlloSure Testing CareDx Brings Innovative Non-Invasive Transplant Monitoring to Patients Internationally with AlloSeq cfDNA CareDx, Inc. (Nasdaq: CDNA)...
Variational AI Secures $5.5M to Launch AI for Drug Discovery
New funding to fuel market expansion of compute efficient foundation model for biopharmaceutical companies Variational AI, the company behind Enki™, an advanced foundation model for...
Alzamend Neuro Completes Novel Head Coil for Phase II Trials
Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in healthy, Alzheimer’s disease,...
Thetis Pharmaceuticals Unveils TP-317 Data at ECCO 2025
Phase 1a Clinical Results Demonstrate a Favorable Safety Profile and BLT1 Engagement In Healthy Volunteers Preclinical Data Highlight TP-317’s Anti-Inflammatory, Epithelial Barrier-Protective Effects Thetis Pharmaceuticals...
Kiromic BioPharma Reports 10-Month Progression-Free Survival
Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) reports continued favorable efficacy results from the 10-month follow-up visit for the fourth patient enrolled in its...
Novotech Partners with Wonju Severance for Clinical Research
Novotech, a global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced...
Celltrion Expands Biosimilar Portfolio with EU Approval
Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® (CT-P42, aflibercept), a biosimilar to Eylea® to treat multiple...